Zinc, future mono/adjunctive therapy for depression: Mechanisms of antidepressant action

Pharmacological Reports

Volumn 67, Issue 3, 2015, Pages 659-662

  Nowak, Gabriel ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

5 HT1A; Depression; GPR39; NMDA; Zinc

Indexed keywords

ANTIDEPRESSANT AGENT; ZINC;

ANIMAL; CHEMISTRY; COMBINATION DRUG THERAPY; DEPRESSION; FORECASTING; HUMAN; METABOLISM; PSYCHOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; DRUG THERAPY, COMBINATION; FORECASTING; HUMANS; ZINC;

EID: 84927947114     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2015.01.015     Document Type: Review

References (57)

1. A. Takeda Movement of zinc and its functional significance in the brain Brain Res Rev 34 3 2000 137 148
2. W. Swardfager, N. Herrmann, R.S. McIntyre, G. Mazereeuw, K. Goldberger, and D.S. Cha Potential roles of zinc in the pathophysiology and treatment of major depressive disorder Neurosci Biobehav Rev 37 5 2013 911 929
3. B. Szewczyk Zinc homeostasis and neurodegenerative disorders Front Aging Neurosci 5 2013 33 10.3389/fnagi.2013.00033
4. B. Szewczyk, M. Kubera, and G. Nowak The role of zinc in neurodegenerative inflammatory pathways in depression Prog Neuropsychopharmacol Biol Psychiatry 35 3 2011 693 701
5. M. Siwek, B. Szewczyk, D. Dudek, K. Styczeń, M. Sowa-Kućma, and K. Młyniec Zinc as a marker of affective disorders Pharmacol Rep 65 6 2013 1512 1518
6. W. Swardfager, N. Herrmann, G. Mazereeuw, K. Goldberger, T. Harimoto, and K.L. Lanctot Zinc in depression: a meta-analysis Biol Psychiatry 74 12 2013 872 878
7. S.M. Lehto, T. Tolmunen, A. Ruusunen, S. Voutilainen, T.P. Tuomainen, and J. Kauhanen Serum zinc and the risk of depression in men: observations from a 20-year follow-up study Biol Psychiatry 77 3 2015 e11 e12
8. W. Swardfager, N. Herrmann, G. Mazereeuw, and K.L. Lanctôt Reply to: serum zinc and the risk of depression in men: observations from a 20-year follow-up study Biol Psychiatry 77 3 2015 e13 e14
9. U. Doboszewska, M. Sowa-Kućma, K. Młyniec, B. Pochwat, M. Hołuj, and B. Ostachowicz Zinc deficiency in rats is associated with up-regulation of hippocampal NMDA receptor Prog Neuropsychopharmacol Biol Psychiatry 56 2014 254 263
10. P.W. Gold The organization of the stress system and its dysregulation in depressive illness Mol Psychiatry 2014 10.1038/mp.2014.163
11. K. Cies̈lik, M. Sowa-Kućma, G. Ossowska, B. Legutko, M. Wolak, and W. Opoka Chronic unpredictable stress-induced reduction in the hippocampal brain-derived neurotrophic factor (BDNF) gene expression is antagonized by zinc treatment Pharmacol Rep 63 2 2011 537 543
12. L. Tao, Y. Zheng, Z. Shen, Y. Li, X. Tian, and X. Dou Psychological stress-induced lower serum zinc and zinc redistribution in rats Biol Trace Elem Res 155 1 2013 65 71
13. J. Lai, A. Moxey, G. Nowak, K. Vashum, K. Bailey, and M. McEvoy The efficacy of zinc supplementation in depression: systematic review of randomised controlled trials J Affect Disord 136 1-2 2012 e31 e39
14. G. Nowak, M. Siwek, D. Dudek, and A. Zieba Pilc. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study Pol J Pharmacol 55 6 2003 1143 1147
15. M. Siwek, D. Dudek, I.A. Paul, M. Sowa-Kućma, A. Zieba, and P. Popik Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study J Affect Disord 118 1-3 2009 187 195
16. Z. Solati, S. Jazayeri, M. Tehrani-Doost, S. Mahmoodianfard, and M.R. Gohari Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial Nutr Neurosci 2014 10.1179/1476830513Y.0000000105
17. M. Gili, M. García Toro, S. Armengol, J. García-Campayo, A. Castro, and M. Roca Functional impairment in patients with major depressive disorder and comorbid anxiety disorder Can J Psychiatry 58 12 2013 679 686
18. A. Partyka, M. Jastrzębska-Więsek, B. Szewczyk, K. Stachowicz, A. Sławińska, and E. Poleszak Anxiolytic-like activity of zinc in rodent tests Pharmacol Rep 63 4 2011 1050 1055
19. M. Torabi, M. Kesmati, H.E. Harooni, and H.N. Varzi Effects of nano and conventional zinc oxide on anxiety-like behavior in male rats Indian J Pharmacol 45 5 2013 508 512
20. M.S. Abdel-Maksoud, M.I. Abdel-hamid, and Y.M. Moustafa NMDA/glutamate mechanism of anxiolytic-like actions of zinc in Vogel conflict test in mice IOSR J Pharm 2 5 2012 4 12
21. M. Sayyah, A. Olapour, Y.S. Saeedabad, R. Yazdan Parast, and A. Malayeri Evaluation of oral zinc sulfate effect on obsessive-compulsive disorder: a randomized placebo-controlled clinical trial Nutrition 28 9 2012 892 895
22. K. Młyniec, C.L. Davies, I. Gómez de Agüero Sánchez, K. Pytka, B. Budziszewska, and G. Nowak Essential elements in depression and anxiety. Part I Pharmacol Rep 66 4 2014 534 544
23. G. Nowak, and M. Schlegel-Zawadzka Alterations in serum and brain trace element levels after antidepressant treatment: part I. Zinc Biol Trace Elem Res 67 1 1999 85 92
24. S.R. Lamont, A. Paulls, and C.A. Stewart Repeated electroconvulsive stimulation but not antidepressant drugs, induces mossy fiber sprouting in the rat hippocampus Brain Res 893 1-2 2001 53 58
25. M. Sowa-Kucma, M. Kowalska, M. Szlosarczyk, K. Golembiowska, W. Opoka, and B. Bas Chronic treatment with zinc and antidepressants induces enhancement of presynaptic/extracellular zinc concentration in the rat prefrontal cortex Amino Acids 40 1 2011 249 258
26. V.A. Vaidya, J.A. Siuciak, F. Du, and R.S. Duman Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures Neuroscience 89 1 1999 157 166
27. K. Młyniec, B. Budziszewska, W. Reczynski, U. Doboszewska, A. Pilc, and G. Nowak Zinc deficiency alters responsiveness to antidepressants in mice Pharmacol Rep 65 3 2013 579 592
28. P. Tu, J. Gibon, and A. Bouron The TRPC6 channel activator hyperforin induces the release of zinc and calcium from mitochondria J Neurochem 112 1 2010 204 213
29. A.O. Rosa, J. Lin, J.B. Calixto, A.R.S. Santos, and A.L.S. Rodrigues Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice Behav Brain Res 144 1-2 2003 87 93
30. E. Poleszak, B. Szewczyk, A. Wlaź, S. Fidecka, P. Wlaź, and A. Pilc d-Serine, a selective glycine/N-methyl-d-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice Pharmacol Rep 60 6 2008 996 1000
31. B. Szewczyk, E. Poleszak, M. Sowa-Kućma, A. Wróbel, S. Słotwiński, and J. Listos The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test Amino Acids 39 1 2010 205 217
32. M. Mellone, S. Pelucchi, L. Alberti, A. Genazzani, M. Di Luca, and F. Gardoni Zinc transporter-1 (ZNT-1): a novel NMDA receptor-binding protein at postsynaptic density J Neurochem 2014 10.1111/jnc.12968
33. A.M. Vergnano, N. Rebola, L.P. Savtchenko, P.S. Pinheiro, M. Casado, and B.L. Kieffer Zinc dynamics and action at excitatory synapses Neuron 82 5 2014 1101 1114
34. B. Szewczyk, E. Poleszak, P. Wlaź, A. Wróbel, E. Blicharska, and A. Cichy The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test Prog Neuropsychopharmacol Biol Psychiatry 33 2 2009 323 329
35. S. Barrondo, and J. Sallés Allosteric modulation of 5-HT(1A) receptors by zinc: binding studies Neuropharmacology 56 2 2009 455 462
36. 2+-sensing receptor: a new target in antidepressant development? J Affect Disord 174 2015 89 100
37. B. Holst, K.L. Egerod, E. Schild, S.P. Vickers, S. Cheetham, and L.O. Gerlach GPR39 signaling is stimulated by zinc ions but not by obestatin Endocrinology 148 1 2007 13 20
38. K. Młyniec, B. Budziszewska, W. Reczyński, M. Sowa-Kućma, and G. Nowak The role of the GPR39 receptor in zinc deficient-animal model of depression Behav Brain Res 238 2013 30 35
39. K. Młyniec, U. Doboszewska, B. Szewczyk, M. Sowa-Kućma, P. Misztak, and W. Piekoszewski The involvement of the GPR39-Zn(2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims Neuropharmacology 79 2014 290 297
40. K. Młyniec, B. Budziszewska, B. Holst, B. Ostachowicz, and G. Nowak GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB/BDNF down-regulation in the hippocampus Int J Neuropsychopharmacol 2014 10.1093/ijnp/pyu002
41. R. Hurst, H. Rollema, and D. Bertrand Nicotinic acetylcholine receptors: from basic science to therapeutics Pharmacol Ther 137 1 2013 22 54
42. E. Vazquez-Gomez, and J. Garcia-Colunga Neuronal nicotinic acetylcholone receptors are modulated by zinc Neuropharmacology 56 6-7 2009 1035 1040
43. J. García-Colunga, E. Vázquez-Gómez, and R. Miledi Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors Pharmacogenomics J 4 6 2004 388 393
44. J. García-Colunga, U. Godoy-García, and E. Vázquez-Gómez Interaction of bupropion and zinc with neuronal nicotinic acetylcholine receptors Neuropharmacology 61 8 2011 1202 1209
45. H.M. Abelaira, G.Z. Reus, M.V. Neotti, and J. Quevedo The role of mTOR in depression and antidepressant responses Life Sci 101 2014 10 14
46. N. Hay, and N. Sonenberg Upstream and downstream of mTOR Genes Dev 18 2004 1926 1945
47. J.M. Ryu, M.Y. Lee, S.P. Yun, and H.J. Han Zinc chloride stimulates DNA synthesis of mouse embryonic stem cells: involvement of PI3K/Akt, MAPKs, and mTOR J Cell Physiol 218 3 2009 558 567
48. J.P. McClung, T.N. Tarr, B.R. Barnes, A.G. Scrimgeour, and A.J. Young Effect of supplemental dietary zinc on the mammalian target of rapamycin (mTOR) signaling pathway in skeletal muscle and liver from post-absorptive mice Biol Trace Elem Res 118 1 2007 65 76
49. X. Li, and R.S. Jope Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 35 11 2010 2143 2154
50. R. Ilouz, O. Kaidanovich, D. Gurwitz, and H. Eldar-Finkelman Inhibition of glycogen synthase kinase-3β by divalent zinc ions: insight into the insulin-mimetic action of zinc Biochem Biophys Res Commun 295 1 2002 102 106
51. W. Lasoń, B. Budziszewska, A. Basta-Kaim, M. Kubera, and M. Maes New trends in the neurobiology and pharmacology of affective disorders Pharmacol Rep 65 6 2013 1441 1450
52. G. Nowak, B. Legutko, B. Szewczyk, M. Papp, M. Sanak, and A. Pilc Zinc treatment induces cortical brain-derived neurotrophic factor gene expression Eur J Pharmacol 492 1 2004 57 59
53. A. Cichy, M. Sowa-Kućma, B. Legutko, L. Pomierny-Chamioło, A. Siwek, and A. Piotrowska Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors Pharmacol Rep 61 6 2009 1184 1191
54. M. Sowa-Kućma, B. Legutko, B. Szewczyk, K. Novak, P. Znojek, and E. Poleszak Antidepressant-like activity of zinc in rats: further behavioral and molecular evidence J Neural Transm 115 12 2008 1621 1628
55. D.R. Morris, and C.W. Levenson Zinc regulation of transcriptional activity during retinoic acid-induced neuronal differentiation J Nutr Biochem 24 11 2013 1940 1944
56. S.D. Gower-Winter, R.S. Corniola, T.J. Morgan Jr., and C.W. Levenson Zinc deficiency regulates hippocampal gene expression and impairs neuronal differentiation Nutr Neurosci 16 4 2013 174 182
57. C.W. Levenson, and D. Morris Zinc and neurogenesis: making new neurons from development to adulthood Adv Nutr 2 2 2011 96 100